Prevention Works

Swine health solutions with you in mind

Others

BOEHRINGER INGELHEIM INVESTS FURTHER IN ANIMAL HEALTH

Boehringer Ingelheim Vetmedica has announced it will expand its operations in St Joseph, Missouri, with a $150 million project. Boehringer Ingelheim Vetmedica said today it would expand its St. Joseph operations with a $150 million project that will create 124 jobs, reports The Kansas City Star.

Ileitis

VACCINATION VS. ENTEROPATHY CUTS NEED FOR ANTIMICROBIALS

Boehringer Ingelheim DENMARK - Two researchers from Boehringer-Ingelheim Vetmedica in Copenhagen have published a paper showing a highly significant reduction in the use of antimicrobials after vaccination of pigs against porcine proliferative enteropathy in a Danish specific-pathogen-free (SPF) herd.

Circovirus

BOEHRINGER INGELHEIM 2008 PCVAD RESEARCH AWARD

Boehringer Ingelheim Vetmedica, Inc., (BIVI) announces the recipients of its annual research award program directed at porcine circovirus associated disease (PCVAD). The $75,000 PCVAD Research Awards will fund three research studies designed to improve the industry’s understanding and management of this devastating disease.

Circovirus

EUROPEAN PCV2 RESEARCH AWARDS

EU - The EU PCVD Consortium announced awards for Professor Hans Nauwynck and Professor Joaquim Segalés in its June 2008 newsletter.